Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

SHE:002923 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	245.85	256.17	206.51	213.86	221.03	250.3
Trading Asset Securities	0.05	0.05	0.07	0.05	0.06	0.09
Cash & Short-Term Investments	245.9	256.22	206.58	213.91	221.09	250.39
Cash Growth	13.12%	24.03%	-3.43%	-3.25%	-11.70%	-15.32%
Accounts Receivable	215.65	197.98	213.41	212.11	202.31	160
Other Receivables	4.53	2.61	4.92	3.95	4.03	36.23
Receivables	220.18	200.59	218.34	216.07	206.34	196.23
Inventory	374.19	394.61	442.01	415.45	440.86	335.53
Other Current Assets	6.95	4.83	18.83	21.3	77.95	25.99
Total Current Assets	847.21	856.26	885.75	866.73	946.25	808.14
Property, Plant & Equipment	1,046	1,082	1,209	1,250	1,224	972.57
Long-Term Investments	-	-	-	0.5	0.5	0.5
Other Intangible Assets	62.6	63	64.42	66.05	67.62	69
Long-Term Deferred Tax Assets	13.48	13.9	10.35	10.67	10.8	8.61
Long-Term Deferred Charges	8.55	9.78	13.66	19.93	12.81	13.31
Other Long-Term Assets	3.04	3.42	10.55	14.27	25.23	37.31
Total Assets	1,981	2,029	2,194	2,228	2,287	1,909

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	132.29	143.53	223.36	153.79	213.41	152.5
Accrued Expenses	21.29	115.34	112.39	115.96	178.09	162.56
Short-Term Debt	93.31	132.86	25.04	60.54	62.94	33
Current Portion of Long-Term Debt	91.96	86.69	106.05	68.82	25.28	-
Current Portion of Leases	-	1.1	2.22	2.11	1.75	2.52
Current Income Taxes Payable	8.56	-	-	2.26	11.47	0.14
Current Unearned Revenue	10.05	17.92	12.46	10.89	46.68	14.29
Other Current Liabilities	140.77	38.02	42.65	31.93	50.11	57.86
Total Current Liabilities	498.22	535.47	524.16	446.31	589.74	422.87
Long-Term Debt	288.67	309.89	361.67	433.87	377.49	250
Long-Term Leases	1.49	1.77	5.56	7.48	0.98	1.08
Long-Term Unearned Revenue	132.46	136.77	146.52	157.57	120.99	119.74
Long-Term Deferred Tax Liabilities	0.64	0.71	1.73	2.31	0.57	-
Other Long-Term Liabilities	5.87	5.58	1.89	1.07	1.18	3.6
Total Liabilities	927.34	990.19	1,042	1,049	1,091	797.28

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	334.89	334.89	334.89	334.89	239.21	185.71
Additional Paid-In Capital	183.18	183.18	183.18	183.18	278.87	346.23
Retained Earnings	535.93	520.33	634.03	661.08	677.91	594.08
Treasury Stock	-	-	-	-	-	-13.86
Comprehensive Income & Other	-0	-0	0	-0	-	-
Shareholders' Equity	1,054	1,038	1,152	1,179	1,196	1,112
Total Liabilities & Equity	1,981	2,029	2,194	2,228	2,287	1,909

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	475.43	532.32	500.54	572.82	468.43	286.61
Net Cash (Debt)	-229.53	-276.1	-293.96	-358.91	-247.33	-36.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.63	-0.83	-0.88	-1.07	-0.73	-0.11
Filing Date Shares Outstanding	334.89	334.89	334.89	334.89	334.89	337.99
Total Common Shares Outstanding	334.89	334.89	334.89	334.89	334.89	337.99
Working Capital	348.99	320.79	361.59	420.42	356.5	385.27
Book Value Per Share	3.15	3.10	3.44	3.52	3.57	3.29
Tangible Book Value	991.4	975.4	1,088	1,113	1,128	1,043
Tangible Book Value Per Share	2.96	2.91	3.25	3.32	3.37	3.09
Buildings	-	540.49	526.75	495.64	399.88	258.75
Machinery	-	1,215	1,173	966.81	848.89	518.23
Construction In Progress	-	19.09	60.3	207.91	295.77	450.37

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error